Business Wire

Brightcove Launches ‘Ad Monetization’ Service for Media Clients, Establishes Global Advertising Operations Team

Share

Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, today announced the launch of Brightcove Ad Monetization, a new bespoke service designed for media companies to better monetize their content. To supplement the service, the company also created a new global advertising operations team to support media organizations and help them maximize their advertising strategy and revenue.

“Advertising-supported streaming is a fast-growing, multi-billion-dollar business we have supported for many years,” said Marc DeBevoise, CEO of Brightcove. “As a valued partner to our media customers, Brightcove Ad Monetization extends our commitment to providing them with the best products and services to power their video content, optimize their advertising strategy, and now – for the first time – truly drive and maximize their advertising revenue.”

Brightcove Ad Monetization builds on Brightcove’s recently announced strategic partnership with Magnite, the world's largest independent sell-side advertising platform. Through the integration of Magnite and SpringServe, Brightcove now offers an advertising monetization service with end-to-end solutions for media companies to generate additional revenue from their advertising strategy.

Brightcove Ad Monetization will help media companies realize maximum, measurable returns on advertising with actionable insights. The solution supports the monetization of live and video-on-demand (VOD) content with improved yield optimization to fill unsold ad inventory and increase revenue. It includes client-side advertising insertion (CSAI) and server-side advertising insertion (SSAI) capabilities for web players, iOS, Android and connected TV platforms. Brightcove Ad Monetization also seamlessly integrates into independent and existing advertising servers, including Google Ad Manager and FreeWheel.

Companies that utilize the service will benefit from the expertise of Brightcove and receive direct support from its newly established global advertising operations team. Under the leadership of David Beck, Chief Strategy and Corporate Development Officer, the new team will consult directly with clients to optimize their advertising strategy, budget and content. From onboarding to implementation and refining the strategy, the team will tap into its deep insights and expertise to help customers every step of the way, no matter where they are on their advertising journey.

Beck has appointed Michael Dorf as the first Vice President of Global Ad Operations to build the team and help media companies monetize their content. “Advertising is constantly evolving and increasingly complicated for many media companies. Brightcove is determined to reduce the friction in the process, making it easier and more profitable for our clients,” shared Beck. “To do this, we built a new expert team. I’m excited to welcome Michael Dorf to lead our global advertising operations. His wealth of knowledge and experience in the media and advertising world will help customers better deliver the right ads to the right people to improve delivery and revenue.”

Dorf is an experienced revenue operations leader with 15 years of experience in the industry. He most recently worked at TelevisaUnivision as the Vice President of Revenue Operations, where he successfully rebuilt a cross-functional operations team to support direct and programmatic sales channels. Prior to that, he held various senior leadership roles with FreeWheel, a Comcast company, Condé Nast, and Maker Studios, a subsidiary of The Walt Disney Company.

For more information, visit Brightcove.com.

About Brightcove Inc.

Brightcove creates the world’s most reliable, scalable, and secure streaming technology solutions to build a greater connection between companies and their audiences, no matter where they are or on which devices they consume content. In more than 60 countries, Brightcove’s intelligent video platform enables businesses to sell to customers more effectively, media leaders to stream and monetize content more reliably, and every organization to communicate with team members more powerfully. With two Technology and Engineering Emmy® Awards for innovation, uptime that consistently leads the industry, and unmatched scalability, we continuously push the boundaries of what video can do. Follow LinkedIn, Twitter, Facebook and Instagram. Visit www.brightcove.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
Joseph J. Nuñez, Director of Global Communications and Public Relations
jnunez@brightcove.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release

Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release

MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye